OR HCR4

Designates May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month in Oregon

Ehlers-Danlos syndromes (EDS) comprise 13 heritable connective tissue disorders affecting 1 in 5,000 people, characterized by joint hypermobility, skin hyperextensibility, and tissue fragility

Hypermobility spectrum disorders (HSD) cause joint hypermobility, instability, injury, pain, fatigue, headaches, gastrointestinal problems, and autonomic dysfunction

No cure exists for EDS or HSD; treatment focuses on symptom management, often requiring multiple medical specialists

Directs that a copy of the resolution be presented to the Ehlers-Danlos Society